Loading
companiesCompany
MIM Software (GE HealthCare)
Contouring, image fusion, and dosimetry software (MIM Maestro, SurePlan) for radiotherapy and radioligand therapy, acquired by GE HealthCare in 2024.
Overview
MIM Software, based in Cleveland and acquired by GE HealthCare in 2024, makes contouring, image fusion and dosimetry software, including MIM Maestro and SurePlan, for radiotherapy and radioligand therapy. Its Contour ProtégéAI performs auto-contouring, its PET/CT fusion supports planning, and its personalised dosimetry serves lutetium-177 and yttrium-90 therapies. OnCo links it to AI auto-contouring and adaptive planning, SPECT and bone scan imaging, and radioligand therapy with beta emitters. Whether personalised dosimetry becomes standard for radioligand therapy, rather than fixed dosing, is the open question its tools are built for. The radioligand therapy page carries the wider evidence.
Similar pages
- CompanyMVision AI
Shares AI auto-contouring and adaptive planning and the tag supporting.
- CompanyLimbus AI
Shares AI auto-contouring and adaptive planning and the tag supporting.
- CompanyTheraPanacea
Shares AI auto-contouring and adaptive planning and the tag supporting.
- CompanyRaySearch Laboratories
Shares AI auto-contouring and adaptive planning and the tag supporting.
- TechnologyNuclear medicine and total-body PET hardware
Shares SPECT & bone scan, Radioligand therapy (beta emitters) and the tag supporting.
- TechnologyRadionuclide generators and cold kits
Shares SPECT & bone scan and the tag supporting.
- TechnologyAI compute and model platforms for oncology
Shares AI auto-contouring and adaptive planning and the tag supporting.
- TechnologyRadiotherapy treatment planning and QA software
Shares AI auto-contouring and adaptive planning and the tag supporting.
Software in use
The software of oncology →Commercial and regulated products that this organisation sells. Each card says what is behind it: a regulator's database, the literature, a public body's list, or only the company's own words. Listing is not endorsement, and a clearance is a regulatory fact, not a clinical one.
MIM's deep-learning contouring product, cleared separately from the rest of the suite.
Contouring, registration and dosimetry software used across radiation oncology and nuclear medicine, including dosimetry for radioligand therapy.